Please login to the form below

Not currently logged in
Email:
Password:

Javlor

This page shows the latest Javlor news and features for those working in and with pharma, biotech and healthcare.

NICE rejects Pierre Fabre's bladder cancer drug Javlor

NICE rejects Pierre Fabre's bladder cancer drug Javlor

NICE rejects Pierre Fabre's bladder cancer drug Javlor. Says drug received final draft 'no' because pharma company failed to prove efficacy. ... But having done so NICE nevertheless decided Javlor's high cost and 'inconclusive evidence' meant it couldn't

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics